Overview
Balance Sheet
Cash Flow
Growth Analysis
2024
2023
2022
2021
2020
Profitability Metrics
Gross Margin
23.92%
Operating Margin
4.29%
Net Margin
2.59%
Efficiency Metrics
Revenue per Expense Ratio
1.04
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
9.08%
Income Tax Rate
21.44%
EPS
0.9100000000
Balance Sheet Analysis
Current Ratio
1.73
Cash Ratio
0.28
Working Capital
$80.57M
Debt to Equity
0.48
Debt to Assets
24.36%
Equity Ratio
51.18%
Cash Flow Analysis
Operating Cash Flow Ratio
7.54%
Free Cash Flow Ratio
5.59%
CapEx to Revenue
1.95%
Dividends Paid
$10.64M
Stock Buybacks
$9.55M
Total Shareholder Returns
$20.20M
Cash Position Change
6.43%
Key Takeaways (2024 FY)
Increased dividend payments by 1.41%
Detailed Growth Metrics
Core Performance
Revenue
13.03%
Net Income
-59.93%
EPS
-63.75%
Operating Income
-50.47%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
53.66%
Operating Cash Flow
-39.61%
Free Cash Flow
-52.83%
Balance Sheet Health
Assets
179.11%
Debt
667.26%
Book Value per Share
66.97%
Inventory
181.29%
Shareholder Returns
Dividends per Share
1.41%
Shares Outstanding
10.96%
Long Term Trends
3Y Revenue/Share
8.64%
5Y Revenue/Share
29.40%
3Y Dividend/Share
1.24%
5Y Dividend/Share
1.80%